首页> 外文期刊>Enzyme and Microbial Technology >Biocatalytic preparation of a chiral synthon for a vasopeptidase inhibitor: enzymatic conversion of N-2-[N-phenylmethoxy)carbonyl] L-homocysteinyl]-L-lysine (1-> 1 ')-disulfide to [4S-(4I,7I,10aJ)] 1-octahydro-5-oxo-4-[phenylmethoxy)carbonyl]amino]-7
【24h】

Biocatalytic preparation of a chiral synthon for a vasopeptidase inhibitor: enzymatic conversion of N-2-[N-phenylmethoxy)carbonyl] L-homocysteinyl]-L-lysine (1-> 1 ')-disulfide to [4S-(4I,7I,10aJ)] 1-octahydro-5-oxo-4-[phenylmethoxy)carbonyl]amino]-7

机译:血管肽酶抑制剂的手性合成子的生物催化制备:N-2- [N-苯基甲氧羰基] L-高半胱氨酰基] -L-赖氨酸(1-> 1')-二硫化物的酶促转化为[4S-(4I,7I) ,10aJ)] 1-八氢-5-氧代-4- [苯基甲氧基)羰基]氨基] -7

获取原文
获取原文并翻译 | 示例
           

摘要

4S-(4I.7I,10aJ)]1-Octahydro-5-oxo-4-[phenylmethoxy)carbonyl]amino]-7H-pyr ido-[2,1-b] [1,3]thiazepine-7-carboxylic acid methyl ester (BMS-199541-01) is a key chiral intermediate for the synthesis of Omapatrilat (BMS-186716), a new vasopeptidease inhibitor under development. By using a selective enrichment culture technique we have isolated a strain of Sphingomonas paucimobilis SC 16113, which contains a novel L-lysine epsilon-aminotransferase. This enzyme catalyzed the oxidation of the epsilon-amino group of lysine in the dipeptide dimer N-2-[N[phenyl-methoxy)-carbonyl] L-homocysteinyl] L-lysine)1,1-disulphide (BMS-201391-01) to produce BMS-199541-01. The aminotransferase reaction required alpha-ketoglutarate as the amino acceptor. Glutamate formed during this reaction was recycled back to alpha-ketoglutarate by glutamate oxidase from Streptomyces noursei SC 6007. Fermentation processes were developed for growth of S. paucimobilis SC 16113 and S. noursei SC 6007 for the production of L-lysine epsilon-amino transferase and glutamate oxidase, respectively. L-lysine epsilon-aminotransferase was purified to homogeneity and N-terminal and internal peptides sequences of the purified protein were determined. The mot wt of L-lysine epsilon-aminotransferase is 81 000 Da and subunit size is 40 000 Da. L-lysine epsilon-aminotransferase gene (lat gene) from S. paucimobilis SC 16113 was cloned and overexpressed in Escherichia coli. Glutamate oxidase was purified to homogeneity from S. noursei SC 6003. The mol wt of glutamate oxidase is 125 000 Da and subunit size is 60 000 Da. The glutamate oxiadase gene from S. noursei SC 6003 was cloned and expressed in Streptomyces lividans. The biotransformation process was developed for the conversion of BMS-201391-01 to BMS-199541-01 by using L-lysine epsilon-aminotransferase expressed in E. coli. In the biotransformation process, for conversion of BMS-201391-01 (CBZ protecting group) to BMS-199541-01, a reaction yield of 65-70 65-70 M% was obtained depending upon reaction conditions used in the process. Phenylacetyl or phenoxyacetyl protected analogues of BMS-201391-01 also served as substrates for L-lysine epsilon-aminotransferase giving reaction yields of 70 M% for the corresponding BMS-199541-01 analogs. Two other dipeptides N-[N[(phenylmethoxy)carbonyl]-L-methionyl]-L-lysine (BMS-203528) and N,2-[S-acetyl-N-[(phenylmethoxy)carbonyl]-L-homocysteinyl]-L-lysine (BMS-204556) were also substrates for L-lysine epsilon-aminotransferase. N-alpha-protected (CBZ or BOC)-L-lysine were also oxidized by L-lysine E-aminotransferase. (C) 2000 Elsevier Science Inc. All rights reserved. [References: 32
机译:4S-(4I.7I,10aJ)] 1-八氢-5-氧代-4- [苯基甲氧基)羰基]氨基] -7H-吡咯基-[2,1-b] [1,3]噻氮平-7-羧基酸甲酯(BMS-199541-01)是合成Omapatrilat(BMS-186716)的关键手性中间体,Omapatrilat是一种正在开发的新型血管肽酶抑制剂。通过使用选择性富集培养技术,我们分离出了一种新孢子菌鞘氨醇单胞菌SC 16113菌株,其中含有新型的L-赖氨酸ε-氨基转移酶。该酶催化二肽二聚体N-2- [N [苯基[甲氧基]-羰基] L-高半胱氨酰基] L-赖氨酸)1,1-二硫化物中赖氨酸的ε-氨基氧化(BMS-201391-01 )以生成BMS-199541-01。氨基转移酶反应需要α-酮戊二酸酯作为氨基受体。在该反应过程中形成的谷氨酸被来自Nostrsei SC 6007的谷氨酸氧化酶循环回α-酮戊二酸。开发了发酵过程以生产p.ci. paucimobilis SC 16113和S. noursei SC 6007,以生产L-赖氨酸ε-氨基转移酶。和谷氨酸氧化酶。将L-赖氨酸ε-氨基转移酶纯化至均质,并确定纯化蛋白的N-末端和内部肽序列。 L-赖氨酸ε-氨基转移酶的mot wt为81 000 Da,亚基大小为40 000 Da。克隆了来自杆状链球菌SC 16113的L-赖氨酸ε-氨基转移酶基因(lat基因)并在大肠杆菌中过表达。从S. noursei SC 6003中纯化出谷氨酸氧化酶至同质。谷氨酸氧化酶的mol wt为125 000 Da,亚基大小为60000 Da。克隆了来自链霉菌SC 6003的谷氨酸氧合酶基因并在青霉链霉菌中表达。通过使用在大肠杆菌中表达的L-赖氨酸ε-氨基转移酶,开发了将BMS-201391-01转换为BMS-199541-01的生物转化方法。在生物转化过程中,为了将BMS-201391-01(CBZ保护基)转化为BMS-199541-01,根据过程中使用的反应条件,可以获得65-70 65-70 M%的反应产率。 BMS-201391-01的苯乙酰基或苯氧基乙酰基保护的类似物也可用作L-赖氨酸ε-氨基转移酶的底物,相应的BMS-199541-01类似物的反应收率为70 M%。其他两个二肽N- [N [(苯基甲氧基)羰基] -L-甲硫酰基] -L-赖氨酸(BMS-203528)和N,2- [S-乙酰基-N-[(苯基甲氧基)羰基] -L-高半胱氨酸] -L-赖氨酸(BMS-204556)也是L-赖氨酸ε-氨基转移酶的底物。 N-α-保护的(CBZ或BOC)-L-赖氨酸也被L-赖氨酸E-氨基转移酶氧化。 (C)2000 Elsevier Science Inc.保留所有权利。 [参考:32

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号